Story · Medicine & Biotech
'Gene therapy may remain an option after cochlear implants in children with OTOF hearing loss'
1 outlet · first reported by Korea Biomedical Review 20h ago
Coverage, in order
-
20h ago'Gene therapy may remain an option after cochlear implants in children with OTOF hearing loss'
Some cochlear cells may remain functional for years after early cochlear implantation in children with OTOF gene-related hearing loss, a small Korean study of 11 children found, raising the possibility that gene therapy might still be feasible after implantation.Seoul National University Bundang Hos
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.